Profound Medical has scheduled the release of its second-quarter 2026 financial results for August 6. The Toronto-based company said a conference call will follow the announcement, giving investors and market watchers a chance to hear more about the quarterly update.
The company is a commercial-stage medical device business focused on developing and marketing interventional MRI, or iMRI, procedures. The upcoming earnings release is expected to provide a closer look at Profound Medical’s recent financial performance and business progress during the quarter.
Profound Medical trades on Nasdaq under the ticker PROF and on the Toronto Stock Exchange under PRN. For shareholders, the August 6 update will be a key date on the company’s calendar as it reports its latest results and outlines current operating trends.
The announcement was issued by the company in advance of the earnings date. With the results and conference call now on the schedule, attention will turn to the details Profound Medical shares when it reports its second-quarter 2026 figures.
